Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Figure S3 from Tumor-Derived IL33 Promotes Tissue-Resident CD8+ T Cells and Is Required for Checkpoint Blockade Tumor Immunotherapy
  1. Home
  2. Publications
  3. Figure S3 from Tumor-Derived IL33 Promotes Tissue-Resident CD8+ T Cells and Is Required for Checkpoint Blockade Tumor Immunotherapy

Figure S3 from Tumor-Derived IL33 Promotes Tissue-Resident CD8+ T Cells and Is Required for Checkpoint Blockade Tumor Immunotherapy

Authors:
  • Lujun Chen
    Lujun Chen
  • RSRunzi Sun
    Runzi Sun
  • JXJunchi Xu
    Junchi Xu
  • WZWensi Zhai
    Wensi Zhai
  • DZDachuan Zhang
    Dachuan Zhang
  • MYMin Yang
    Min Yang
  • CYCuihua Yue
    Cuihua Yue
  • YCYichao Chen
    Yichao Chen
  • SLSong Li
    Song Li
  • HTHeth Turnquist
    Heth Turnquist
  • JJJingting Jiang
    Jingting Jiang
  • BLBinfeng Lu
    Binfeng Lu

Open Access
Publisher website
Google Scholar
  • 4 April 2023
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2326-6066.22543729
Abstract
No abstract available
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.